Indication
Prostatic cancer metastases imaging
Prostatic cancer metastases imaging refers to a diagnostic procedure indication rather than a distinct medical condition or disease entity. Read more about Prostatic cancer metastases imaging
2 drugs 2 manufacturers
Drugs that treat it
Common Prostatic cancer metastases imaging therapies.
PROSTASCINT (kit for prep indium-111/capromab pendetide)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProstatic cancer metastases imaging refers to a diagnostic procedure indication rather than a distinct medical condition or disease entity.
In clinical oncology, this indication involves using targeted radiopharmaceuticals and cross-sectional or nuclear imaging modalities to visualize secondary malignant neoplasms in male patients diagnosed with prostate adenocarcinoma.
Imaging evaluates hematogenous and lymphatic dissemination, most characteristically targeting osteoblastic skeletal lesions in the axial skeleton, pelvic and retroperitoneal lymph nodes, and less commonly, visceral organs like the liver and lungs.
Clinically, it is performed to stage high-risk primary disease, localize suspected recurrence following biochemical failure, or monitor treatment efficacy across metastatic disease states.
- fda.gov
Prostatic cancer metastases imaging refers to a diagnostic procedure indication rather than a distinct medical condition or disease entity In clinical oncology, this indication involves using targeted radiopharmaceuticals and cross-sectional or nuclear imaging modalities to visualize secondary malignant neoplasms in male patients diagnosed with prostate adenocarcinoma Clinically, it is performed to stage high-risk primary disease, localize suspected recurrence following biochemical failure, or m...
- nih.gov
Prostatic cancer metastases imaging refers to a diagnostic procedure indication rather than a distinct medical condition or disease entity In clinical oncology, this indication involves using targeted radiopharmaceuticals and cross-sectional or nuclear imaging modalities to visualize secondary malignant neoplasms in male patients diagnosed with prostate adenocarcinoma Clinically, it is performed to stage high-risk primary disease, localize suspected recurrence following biochemical failure, or m...
- nih.gov
Imaging evaluates hematogenous and lymphatic dissemination, most characteristically targeting osteoblastic skeletal lesions in the axial skeleton, pelvic and retroperitoneal lymph nodes, and less commonly, visceral organs like the liver and lungs
- pcf.org
Imaging evaluates hematogenous and lymphatic dissemination, most characteristically targeting osteoblastic skeletal lesions in the axial skeleton, pelvic and retroperitoneal lymph nodes, and less commonly, visceral organs like the liver and lungs
Personalize your experience
Follow Prostatic cancer metastases imaging and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.